Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.

J Clin Med · 2022 · PMC9225017 · PMID 35743415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

found reported a decreasing trend in SCH values in 30 patients with AD after 8 weeks of treatment [ 46 ] while Furuhashi et al. found that SCH did not change after 24 weeks of dupilumab treatment in seven patients [ 47 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.